Full-Time

Head of Legal

Confirmed live in the last 24 hours

Orca Bio

Orca Bio

51-200 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Compensation Overview

$175k - $250kAnnually

+ Pre-IPO Equity

Senior

Remote in USA

Category
Legal
Legal & Compliance
Requirements
  • JD degree from an accredited law school
  • 7-10+ years of experience in corporate law
  • Current admission to any state bar in good standing (California preferred)
  • Life Science industry experience
  • Experience with strategic and financing transactions, including IPO, equity, and/or M&A
Responsibilities
  • Advise the Company on strategic and financing transactions, including managing due diligence, drafting and negotiation of transaction documents, and closing
  • Draft, review, and negotiate general and sophisticated corporate and commercial agreements, including licenses, manufacturing, confidentiality, material transfer, consulting, employment, vendor, services, purchasing, outsourcing, software, research, licensing, clinical trial, and data-related agreements
  • Advise the Company on regulatory compliance matters, including FDA regulations, HIPAA regulations, and export controls
  • Represent the Company in regulatory proceedings and litigation
  • Provide general advice and guidance on legal best practices as we approach product approval / launch
  • Efficiently source, manage, and direct outside counsel

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company aims to enhance these therapies to make them safer and more effective, ultimately improving patient outcomes. Orca Bio's products are designed for healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to advance cell therapy treatments, addressing conditions that currently have limited effective options.

Company Stage

Series D

Total Funding

$186.8M

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

11%

1 year growth

16%

2 year growth

36%
Simplify Jobs

Simplify's Take

What believers are saying

  • Orca Bio's promising clinical data, including high relapse-free survival rates, highlight the potential for curative treatments in challenging patient groups.
  • The company's participation in prestigious conferences like the J.P. Morgan Healthcare Conference and the American Society of Hematology Annual Meeting underscores its industry recognition and thought leadership.
  • Orca Bio's strong team culture and commitment to employee value make it an attractive workplace for talented individuals in the biotechnology field.

What critics are saying

  • The competitive landscape in cell therapy and biotechnology requires continuous innovation to maintain a leading position.
  • Clinical trials and regulatory approvals are inherently risky and can lead to delays or failures, impacting the company's progress and financial stability.

What makes Orca Bio unique

  • Orca Bio's focus on high-precision cell therapies for cancer, autoimmune diseases, and genetic blood disorders sets it apart in the biotechnology sector.
  • Their proprietary single-cell precision manufacturing platform offers uniquely-defined products that aim to transform allogeneic cell therapy.
  • Orca Bio's investigational therapies, such as Orca-T and Orca-Q, demonstrate significantly better outcomes with fewer risks compared to standard treatments.

Help us improve and share your feedback! Did you find this helpful?